Rising per capita GDP, enhanced purchasing power, and a surge in inward-bound FDI flows mean that the Indian economy is on its strongest footing in generations. India’s leading industries – notably its life science sector – are reaping the rewards and anticipating rapid market growth. The USD 65 billion Indian pharma market is predicted to…
Country Reports
Healthcare & Life Sciences Review Portugal 2024 – drawing from over 30 interviews with key stakeholders from industry, government, academia, and hospitals – paints a picture of a nation and a sector not without its challenges, but gradually carving out some highly promising niches. Topics covered in this comprehensive and up-to-date new report include deep…
Morocco, and its healthcare sector, have reached a pivotal moment. The North African nation is currently implementing the most ambitious, far-reaching, and comprehensive health system reorganization in its history along with a major shake-up of the regulatory frameworks governing the country’s local pharmaceuticals industry. All of this is occurring within the context of a cross-industry…
Legal & Regulatory
Prepared in association with Lidings, a leading Russian law firm, it should answer any questions linked to regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents.
Market Access & Health Technology Assesment: Brazil is a must-have asset for any company operating in Brazil or looking to enter the market. Prepared in association with Trench Rossi e Watanabe, a leading Brazilian law firm.
Market Access & Health Technology Assesment: Italy is a must-have asset for any company operating in Italy or looking to enter the market. Prepared in association with Baker Mckenzie, a leading Italian law firm.
InFocus
2023 was a year of transformative change and challenge across the global healthcare and life sciences industries. Drawing on PharmaBoardroom’s exclusive interviews and op-eds from across the world in 2023, our latest report tackles some of the year’s key regional trends. It includes everything from the landmark introduction of drug price negotiations in the US…
With the tremendous healthcare momentum that is already underway in the Gulf Cooperation Council (GCC) countries, driven by economic diversification and transformation, the future of healthcare in the region looks bright. Government initiatives such as Saudi Arabia’s Health Sector Transformation Program, a vital component of the country’s economic and social reform roadmap, Vision 2030, coupled…
The global market for biosimilars has soared in recent years, driven by a push from healthcare systems across the world to take advantage of the savings that these products have to offer. This market stood at over USD 15 billion in 2020, having grown at a CAGR of 56 percent since 2015. Moreover, McKinsey estimates…
InFigures
PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will…
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2023 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs, and drug approvals, as well as market-specific executive insight from the PharmaBoardroom archives, this exclusive new report is an excellent jumping-off point…
PharmaBoardroom’s latest report, InFigures: Middle East & Africa (MENA) 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. MENA may be the smallest pharmaceutical market in the world, accounting for just 2 percent of world market, but it has seen remarkable growth over the last few years and is estimated…
